Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Axonal conduction and injury in multiple sclerosis: the role of sodium channels.
Repurposing the NRF2 activator dimethyl fumarate as therapy against synucleinopathy in Parkinson's disease.
Demyelination affects temporal aspects of perception: An optic neuritis study.
Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica.
Peripheral accumulation of newly produced T and B lymphocytes in natalizumab-treated multiple sclerosis patients.
The effect of vitamin a supplementation on biochemical parameters in multiple sclerosis patients.
Dalfampridine sustained-release for symptomatic improvement of walking speed in patients with multiple sclerosis.
Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1.
Effects of rituximab on lymphocytes in multiple sclerosis and neuromyelitis optica.
Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration.
Design, engineering, and production of human recombinant t cell receptor ligands derived from human leukocyte antigen DR2.
Sanofi MS drug nears green light after pass-the-parcel marathon
Copolymer-1 promotes neurogenesis and improves functional recovery after acute ischemic stroke in rats.
Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice.
Substance Name: Amiloride
Single-use autoinjector for peginterferon-β1a treatment of relapsing-remitting multiple sclerosis: safety, tolerability and patient evaluation data from the Phase IIIb ATTAIN study.
Expression and activation by epstein barr virus of human endogenous retroviruses-w in blood cells and astrocytes: inference for multiple sclerosis.
GlaxoSmithKline and Genmab refocus development programme for ofatumumab in autoimmune indications
Control of experimental autoimmune uveoretinitis by low dose T cell vaccination.
Effect of lipoic acid consumption on oxidative stress among multiple sclerosis patients: A randomized controlled clinical trial.
Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord.
Roche's new time-saving subcutaneous formulation of MabThera approved in Europe for the treatment of common forms of non-Hodgkin Lymphoma
No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.
The correlation between symptomatic fatigue to definite measures of gait in people with multiple sclerosis.
Interferon β-1a reduces increased interleukin-16 levels in multiple sclerosis patients.

Pages